| Filed On | Filing |
|---|---|
| 16 Nov 2026 | SCHEDULE 13G/A |
| 13 Nov 2026 |
Form 4: Reed Kendal, Chief Financial Officer
Sold 20,868 shares ($523K) |
| 12 Nov 2026 | 144 |
| 04 Nov 2026 | 10-Q |
| 29 Oct 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
HOUSTON, October 29, 2026 – Innovex International, Inc. (NYSE: INVX) (“Innovex,” the “Company” or “we”) today announced financial and operating results for the third quarter of 2026. |
| 05 Oct 2026 | SCHEDULE 13G/A |
| 09 Sep 2026 |
Form 4: Anderson Adam, Director
Gave up 13,463 shares to cover exercise price or tax ($405K) |
| 09 Sep 2026 |
Form 4: Reddout Mark, President of North America
Gave up 5,049 shares to cover exercise price or tax ($152K) |
| 09 Sep 2026 |
Form 4: Reed Kendal, Chief Financial Officer
Gave up 5,049 shares to cover exercise price or tax ($152K) |
| 13 Aug 2026 | SCHEDULE 13G/A |
| 13 Aug 2026 | SCHEDULE 13G/A |
| 10 Aug 2026 |
Form 4: Innovex Co-invest FUND, L.p., Director and 8 others
Sold 4,954,467 shares ($142M) · Acquired 45,533 shares (Open Market Sale) ($1.31M) |
| 10 Aug 2026 |
Form 4: Amberjack Capital Partners, L.p., Director and 8 others
Sold 5,000,000 shares ($144M) |
| 10 Aug 2026 | SCHEDULE 13D/A |
| 10 Aug 2026 |
8-K: Entry into a Material Definitive Agreement
Certain stockholders named in Schedule 1 hereto (the “Selling Stockholders”) of Innovex International, Inc., a Delaware corporation (the “Company”), propose to sell to Barclays Capital Inc. (“you” or the “Underwriter”) 5,000,000 shares o... |
| 10 Aug 2026 | 424B7 |
| 06 Aug 2026 | 424B7 |
| 05 Aug 2026 |
Form 4: Reddout Mark, President of North America
Sold 10,000 shares ($300K) |
| 04 Aug 2026 | 10-Q |
| 04 Aug 2026 | 144 |
Loading...